Thompson Siegel & Walmsley LLC Sells 25 Shares of Aetna Inc. (AET)

Thompson Siegel & Walmsley LLC trimmed its holdings in Aetna Inc. (NYSE:AET) by 1.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,423 shares of the company’s stock after selling 25 shares during the period. Thompson Siegel & Walmsley LLC’s holdings in Aetna were worth $216,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. NBT Bank N A NY bought a new position in shares of Aetna during the second quarter valued at about $215,000. State of Tennessee Treasury Department lifted its position in shares of Aetna by 26.3% during the second quarter. State of Tennessee Treasury Department now owns 557,814 shares of the company’s stock valued at $84,692,000 after purchasing an additional 116,280 shares in the last quarter. Pictet & Cie Europe SA bought a new position in shares of Aetna during the second quarter valued at about $2,269,000. Swiss National Bank lifted its position in shares of Aetna by 0.8% during the second quarter. Swiss National Bank now owns 1,483,438 shares of the company’s stock valued at $225,230,000 after purchasing an additional 11,100 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its position in shares of Aetna by 4.5% during the second quarter. Cambridge Investment Research Advisors Inc. now owns 36,731 shares of the company’s stock valued at $5,577,000 after purchasing an additional 1,590 shares in the last quarter. 89.58% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Thompson Siegel & Walmsley LLC Sells 25 Shares of Aetna Inc. (AET)” was first published by BBNS and is the sole property of of BBNS. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this piece can be read at https://baseballnewssource.com/markets/thompson-siegel-walmsley-llc-has-216000-stake-in-aetna-inc-aet/1612186.html.

Shares of Aetna Inc. (NYSE AET) traded down 0.06% during midday trading on Friday, hitting $162.68. 1,977,451 shares of the stock were exchanged. Aetna Inc. has a 52-week low of $104.59 and a 52-week high of $164.52. The firm’s 50-day moving average is $157.29 and its 200 day moving average is $145.07. The firm has a market cap of $54.03 billion, a PE ratio of 36.11 and a beta of 0.53.

Aetna (NYSE:AET) last posted its earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, beating analysts’ consensus estimates of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The firm had revenue of $15.52 billion during the quarter, compared to analyst estimates of $15.34 billion. During the same period last year, the firm posted $2.21 earnings per share. Aetna’s revenue for the quarter was down 2.7% compared to the same quarter last year. On average, analysts forecast that Aetna Inc. will post $9.55 earnings per share for the current year.

AET has been the topic of several research reports. Jefferies Group LLC reaffirmed a “hold” rating and issued a $163.00 price objective (up previously from $157.00) on shares of Aetna in a research report on Friday, August 4th. Morgan Stanley initiated coverage on shares of Aetna in a research report on Tuesday, June 6th. They issued an “overweight” rating and a $162.00 price objective on the stock. Zacks Investment Research raised shares of Aetna from a “hold” rating to a “buy” rating and set a $170.00 price objective on the stock in a research report on Tuesday, July 4th. Deutsche Bank AG lifted their price objective on shares of Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a research report on Monday, August 7th. Finally, Credit Suisse Group reaffirmed an “outperform” rating and issued a $165.00 price objective (up previously from $160.00) on shares of Aetna in a research report on Thursday, July 13th. Seven analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $159.04.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22
Tigers Player Might Play All Nine Positions During Same Game
Tigers Player Might Play All Nine Positions During Same Game
Fans Kicked Out of Fenway Park After Racist Banner Hung on Green Monster
Fans Kicked Out of Fenway Park After Racist Banner Hung on Green Monster
Dodgers End Losing Streak at 11 Behind Ace Clayton Kershaw
Dodgers End Losing Streak at 11 Behind Ace Clayton Kershaw
Cleveland Indians Winning Streak Reaches 18
Cleveland Indians Winning Streak Reaches 18


Leave a Reply

 
© 2006-2017 BBNS.